Search for: "Novartis Ag"
Results 361 - 380
of 440
Sorted by Relevance
|
Sort by Date
1 Feb 2021, 11:27 am
Singh considers two cases, Bayer v Natco and Novartis AG v Union of India, to see how compulsory licensing of pharmaceuticals and evergreening of patents are dealt with by the Indian judiciary.Part VII “Lores of IP during wartime”Arpan Banerjee and Dana Beldiman, in Chapter 14, “International Trade Mark Enforcement Under the Versailles Treaty: A Case Study of Sanatogen”, discuss how the Bombay High Court applied IP-related provisions of the Versailles Treaty… [read post]
30 Apr 2019, 7:22 am
Final panellist Jürgen Dressel (ex- Novartis Pharma AG) explained that, going back to basics, the SPC is meant to be a reward for R&D and there should be legal certainty and a harmonised situation for the international market. [read post]
9 Feb 2015, 1:15 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
16 Feb 2015, 1:44 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
9 Feb 2013, 4:04 pm
These statements can also be accessed via the government websites of the countries concerned.Argentina / ArgentineUnión Obrera Molinera and Cargill S.A. specific instance: Statement by the Argentinian NCP, 31 July 2007Australia / AustraliePublic statement by the Australian NCP on the transfer of a specific instance involving an Australian-headquartered enterprise to the Chilean NCP, 1 March 2012 Public statement by the Australian NCP on the transfer of a specific… [read post]
1 May 2024, 1:18 pm
Novartis AG, the 2011 opinion of the U.S. [read post]
14 Sep 2010, 1:29 am
This exclusion has been expensively interpreted by patent office and the courts: notably, the term ‘efficacy’ in the explanation to Section 3(d) of the Patents Act, 1970 has been interpreted in Novartis AG & Another v. [read post]
29 Mar 2011, 9:19 pm
(The IP Factor) Products Actonel (Risedronate) – US: Warner Chilcott files patent infringement complaint against Mylan in response to Para IV certification (Patent Docs) Actos (Pioglitazone) – US: Takeda files patent infringement suit against Apotex following Para IV challenge (Patent Docs) Antara (Fenofibrate) – US: Lupin files patent infringement lawsuits against Mylan, Apotex following Para IV certification (Patent Docs) Drospirenone, Ethinylestradiol – EU: Inventive step,… [read post]
10 Oct 2011, 12:31 am
"We can now confirm that the deadline to submit comments on Case C- 442/11 Novartis AG v Actavis UK Limited is 14 October 2011" writes the UK Intellectual Property Office, which adds "If you would like to comment on this case please e-mail policy@ipo.gsi.gov.uk before 14 October 2011". [read post]
28 Jul 2012, 7:34 pm
Novartis AG’s drug Gleevec (imatinib), which targets a fusion protein responsible for CML, has proved to be highly effective in arresting the disease. [read post]
15 Jun 2011, 4:56 am
(updated) (IP Whiteboard) Canada: Study debunks Chamber of Commerce claims on Canadian patent law (Michael Geist) EU: Opinion of the AG for C-125/10 is out! [read post]
3 Oct 2011, 5:20 am
In addition, Mr Alexander talked the packed auditorium through some interesting procedural decisions, such as Virgin Atlantic v Delta Air on summary judgment, Cephalon v Orchid on interim injunctions or MedImmune v Novartis on expert evidence. [read post]
29 Aug 2013, 8:20 am
Novartis, Case No.: 04-CV-9194 (S.D.N.Y. [read post]
Patent Term Adjustment and Obviousness-Type Double Patenting: Cellect’s Bid for Supreme Court Review
14 Apr 2024, 5:01 am
In Novartis AG v. [read post]
20 May 2024, 4:25 pm
In Novartis AG v. [read post]
9 Sep 2021, 2:02 am
Knockri has partnered with large organizations such as IBM, SAP, Deloitte, Novartis, and many more. [read post]
4 Mar 2011, 5:55 am
This case has to ability to gut summary judgment in any discrimination case (except age) in which a supervisor is accused of having a discriminatory animus. [read post]
22 Dec 2010, 3:01 am
Pfizer Health AB & Anor v Schwarz Pharma AG & Ors (PatLit) US: Briefing updates – AMP v. [read post]
18 Mar 2010, 2:30 am
The case of generic Flomax – Hatch-Waxman backstory to approval of Impax first generic version of Boehringer Ingelheim’s Flomax (FDA Law Blog) Focalin (Dexmethylphenidate), Ritalin (Methylphenidate) - US: Settlement in ADHD patent infringement suits announced - Celgene Corp. and Novartis AG against defendants KV Pharmaceutical Co. and IntelliPharmaCeutics Corp (Patent Docs) (GenericsWeb) Neupogen (Filgrastim) – US: District Court N D Illinois: False marking… [read post]
29 Apr 2011, 7:43 am
Novartis Corp. [read post]
